Disclosures for "Real-time MRI Facilitates Accurate Quantification of Respiratory Impairment in Pompe Disease"
-
An immediate family member of Mrs. Toepert has received research support from German Research Foundation (DFG).
-
Dr. Zeng has nothing to disclose.
-
Dr. Al-Bourini has nothing to disclose.
-
Mr. Lettermann has received research support from DFG.
-
Dr. Olgemoeller has nothing to disclose.
-
Dr. Hofer has nothing to disclose.
-
Prof. Boentert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Boentert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Prof. Boentert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Prof. Boentert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amicus Therapeutics. Prof. Boentert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ITF Pharma. Prof. Boentert has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Almylyx.
-
Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RECARDIO. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Daiichi Sankyo. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Prof. Friede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BiosenseWebster. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Enanta. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VICO Therapeutics. Prof. Friede has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Fresenius Kabi Deutschland GmbH.
-
Mr. Nietert has nothing to disclose.
-
Dr. Voit has received intellectual property interests from a discovery or technology relating to health care.
-
Prof. Frahm has nothing to disclose.
-
The institution of Prof. Uecker has received research support from National Institutes of Health. The institution of Prof. Uecker has received research support from German Centre for Cardiovascular Research. Prof. Uecker has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Seif Amir Hosseini has nothing to disclose.
-
Dr. Schmidt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring and UCB. Dr. Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring and LFB. Dr. Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Schmidt has received research support from Kezar, Novartis and AFM.